The only sera biomarkers that were increased in patients with COVID-19 in the registry that had a history of CVD compared to those without a CVD history were peak CRP (p = 7.98 × 10−5) and kappa Ig FLCs (p = 0.0032). Here, CRP is linked to COVID-19.